Healthcare -
Biotechnology - NASDAQ - GB
$ 0.2925
0.245 %
$ 75.4 M
Market Cap
-0.95
P/E
ADAP - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ADAP - Adaptimmune Therapeutics plc
78.7 M
LAST VALUE
147.39%
2 YEAR CAGR
192.79%
5 YEAR CAGR
16.61%
10 YEAR CAGR